Clinical Trials Browser

Phase 1/2 × folfirinox × 90 days × Clear all

NCT03828799 2026-02-27

FOLFIRINOX-R

Phase 1/2 Completed

13 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

NCT06384560 2026-02-13

PREOPANC-5

Phase 1/2 Recruiting

Gastrointestinal

Localized Pancreatic Adenocarcinoma